Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

974

Participants

Timeline

Start Date

June 29, 2020

Primary Completion Date

December 9, 2021

Study Completion Date

December 23, 2021

Conditions
Acute Migraine
Interventions
DRUG

Zavegepant (BHV-3500)

10 mg IN up to 8 times per month, up to 1 year

Trial Locations (67)

10017

Fieve Clinical Research, Inc, New York

10461

Montefiore Medical Center: Headache Center, The Bronx

13760

Regional Clinical Research, Endwell

14609

Rochester Clinical Research, Inc., Rochester

15236

Preferred Primary Care Physicians, Inc., Pittsburgh

15401

Preferred Primary Care Physicians, Inc., Union

19114

Clinical Research of Philadelphia, LLC, Philadelphia

22911

Charlottesville Medical Research Center, LLC, Charlottesville

23454

Tidewater Integrated Medical Research, Virginia Beach

27405

Headache Wellness Center, Greensboro

27408

PharmQuest LLC, Greensboro

28401

Wilmington Health, PLLC, Wilmington

29464

Coastal Carolina Research Center, Mt. Pleasant

30030

iResearch Atlanta, LLC, Decatur

31406

Meridian Clinical Research, LLC, Savannah

32055

Multi-Specialty Research Associates, Inc., Lake City

32174

Ormond Medical Arts Pharmaceutical Research Center, Ormond Beach

32256

Clinical Neuroscience Solutions, Inc., Jacksonville

32801

Clinical Neuroscience Solutions, Inc., Orlando

32819

Clinical Neuroscience Solutions, Inc., Orlando

33634

Meridien Research, Tampa

35801

Medical Affiliated Research Center, Huntsville

36608

Coastal Clinical Research, LLC, An AMR Co., Mobile

37920

Volunteer Research Group, Knoxville

38119

Clinical Neuroscience Solutions, Inc., Memphis

46011

Community Hospital of Anderson and Madison County Inc, Anderson

46804

Fort Wayne Neurological Center, Fort Wayne

48104

Michigan Headache and Neurological Institute, Ann Arbor

53144

Clinical Investigation Specialist, Inc., Kenosha

55402

Clinical Research Institute, Inc., Minneapolis

63141

Sundance Clinical Research, LLC, St Louis

63303

StudyMetrix Research, City of Saint Peters

65810

Clinvest Research LLC, Springfield

66208

Collective Medical Research, Prairie Village

70043

Crescent City Headache and Neurology Center, Chalmette

72205

Baptist Health Center for Clinical Research, Little Rock

73034

OK Clinical Research LLC, Edmond

73099

Tekton Research, Inc., Yukon

75231

FutureSearch Trials of Dallas, LP, Dallas

77375

DM Clinical Research, Tomball

77566

Red Star Research LLC, Lake Jackson

78731

FutureSearch Trials of Neurology, Austin

83704

Northwest Clinical Trials Inc., Boise

84095

J. Lewis Research, Inc. / Jordan River Family Medicine, South Jordan

84107

Wasatch Clinical Research, LLC, Salt Lake City

85710

Tucson Neuroscience Research, Tucson

87102

Albuquerque Clinical Trials, Inc., Albuquerque

90404

California Medical Clinic for Headache, Santa Monica

90720

Pharmacology Research Institute, Los Alamitos

90806

Collaborative Neuroscience Network, LLC, Long Beach

91316

Pharmacology Research Institute, Encino

91403

California Neuroscience Research Medical Group, Inc., Sherman Oaks

91942

eStudySite, La Mesa

91945

Synergy San Diego, Lemon Grove

92078

Artemis Institute for Clinical Research, San Marcos

92103

Artemis Institute for Clinical Research, San Diego

92660

Wr-Pri, Llc, Newport Beach

97210

Summit Research Network, Portland

98007

Northwest Clinical Research Center, Bellevue

98105

Seattle Women's: Health, Research, Gynecology, Seattle

06416

CT Clinical Research, Cromwell

06905

Ki Health Partners, LLC dba New England Institute for Clinical Research, Stamford

02131

Boston Clinical Trials, Boston

01752

Community Clinical Research Network, Marlborough

02747

Boston Neuro Research Center, South Dartmouth

02451

Medvadis Research Corporation, Waltham

03766

Dartmouth-Hitchcock Heater Road, Lebanon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04408794 - Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine | Biotech Hunter | Biotech Hunter